News
We’re featured on the Innovation Radar’s website as Key Innovator!
26 AUGUST 2024
We are excited to share that River BioMedics B.V. has been recognized as Key Innovator by the EU’s Innovation Radar for our work on the EU-funded Research & Innovation project 3DCardiacHTS! Our work on the development of a fluidic circuit board for cardiac strip formation in HTS plates is now featured on the Innovation Radar’s public website.
River BioMedics Poster session at EUROoCS Milan 2024
02 JULY 2024
We are attending EUROoCS in Milan this week (3rd-5th of July). Find us at the poster session on Friday 5th of July (12:30-14:00):
📌 F-035 – Amélie Bocquet – Rapid-prototyped macro-valves for fluidic control of μ3Dcardiac tissues-on-chip.
📌 F-039 – Chloë Kaal – Maturation induced Titin isoform switching in 3D cardiac stiffening model.
We look forward to seeing you.
Professor John McMurray joins us as a scientific advisor on our lead programme
14 JUNE 2024
We are honoured to welcome Professor John McMurray as a scientific advisor to River BioMedics on our lead programme, a small molecule, disease modifying approach to heart failure with preserved ejection fraction. Professor McMurray is currently Professor of Medical Cardiology and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow.
Prof McMurray’s primary research interests are in heart failure and the cardiovascular consequences of diabetes and chronic kidney disease, with a focus on clinical trials.
He is a Past-President of the Heart Failure Association of the ESC and a Highly Cited Researcher with a H-index of >200.He was awarded an (honorary) OBE in 2019 by Her Majesty the Queen, in recognition of his services to cardiovascular research and in 2020 was awarded the Gold Medal of the European Society of Cardiology, which the society describes as “the highest honour it can bestow on exceptional scientists for their contribution to cardiovascular medicine”.
River BioMedics goes to BioEquity Europe 2024
05 MAY 2024
River BioMedics CEO, Nicky Cooper, will be at the 24th BioEquity Europe on May 12-14 in San Sebastián, Spain.
A great opportunity to talk about our 3D Caridiac Strip technology and share ideas on cardiac drug discovery development.
To learn more go to BioEquity Europe 2024.